Letter | 02 April 2024 Diagnostics Tuberculosis Sierra Leone Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test
Letter | 02 April 2024 Diagnostics Tuberculosis Belarus Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test
Letter Letter | 05 March 2024 Intellectual property and trade Letter: Civil society calls on European Parliament to support global access to medical tools by removing export prohibition in Union compulsory license
Letter Letter | 01 November 2023 Intellectual property and trade Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines
Letter | 21 September 2023 Tuberculosis Azerbaijan Azerbaijan: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Tuberculosis Ukraine Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis